Literature DB >> 9795156

Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase.

W D Hirst1, N Y Cheung, M Rattray, G W Price, G P Wilkin.   

Abstract

The literature describing the expression of 5-HT receptor subtypes by astrocytes is controversial and incomplete. It is clear that primary cultures of astrocytes express receptors of the 5-HT2 family coupled to phospholipase C and of the 5-HT7 receptor family positively coupled to adenylyl cyclase. Cultured astrocytes have also been reported to express receptors of the 5-HT1 family, although the exact subtypes present are unknown. In the present study we have investigated which of the known rat G-protein coupled 5-HT receptor mRNAs are expressed by cultured astrocytes. Reverse transcriptase-polymerase chain reaction (RT-PCR) revealed expression of 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT5B, 5-HT6 and 5-HT7 receptor mRNAs in astrocytes derived from 2-day old rats and cultured for 10-12 days. Messenger RNAs for 5-HT4 and 5-HT5A receptors were not detected. The functional expression of 5-HT1 receptor subtypes was investigated by measuring the ability of 5-HT1 receptor agonists: 8-OH-DPAT (5-HT1A receptors), RU24969 (5-HT1A, 5-HT1B, 5-HT1D, and 5-HT1F receptors) or sumatriptan (5-HT1B, 5-HT1D, and 5-HT1F receptors) to modulate forskolin or isoproterenol stimulated cAMP production. These compounds, at concentrations up to 10 microM, did not significantly attenuate cAMP production. These results indicate that although astrocytes express mRNA for each of the five 5-HT1 receptor subtypes which have been isolated from the rat, these receptors are not coupled to the inhibition of adenylyl cyclase. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795156     DOI: 10.1016/s0169-328x(98)00206-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  21 in total

1.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 2.  5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?

Authors:  Lars Neeb; Jannis Meents; Uwe Reuter
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 3.  Monoamines in glioblastoma: complex biology with therapeutic potential.

Authors:  Seamus Patrick Caragher; Robert Raymond Hall; Riasat Ahsan; Atique U Ahmed
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

4.  5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A).

Authors:  Lauren F Borkowski; Taylor A Craig; Olivia E Stricklin; Katherine A Johnson; Nicole L Nichols
Journal:  Respir Physiol Neurobiol       Date:  2020-06-03       Impact factor: 1.931

Review 5.  A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivo.

Authors:  Milt Teitler; Michael T Klein
Journal:  Pharmacol Ther       Date:  2011-11-17       Impact factor: 12.310

Review 6.  Similarities and differences in mechanisms of phrenic and hypoglossal motor facilitation.

Authors:  Tracy L Baker-Herman; Kristi A Strey
Journal:  Respir Physiol Neurobiol       Date:  2011-07-02       Impact factor: 1.931

7.  Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude.

Authors:  Katharina J Gerhold; Ruth Drdla-Schutting; Silke D Honsek; Liesbeth Forsthuber; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2015-07-01       Impact factor: 6.167

8.  Serotonin 1A receptor agonist increases species- and region-selective adult CNS proliferation, but not through CNTF.

Authors:  Sheila A Arnold; Theo Hagg
Journal:  Neuropharmacology       Date:  2012-08-05       Impact factor: 5.250

Review 9.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 10.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.